These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31566930)
1. Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer. Shi J; Zhang P; Liu L; Min X; Xiao Y Mol Genet Genomic Med; 2019 Nov; 7(11):e982. PubMed ID: 31566930 [TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis. Shi S; Tian B Cancer Biomark; 2019; 24(2):183-193. PubMed ID: 30689556 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression. Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561 [TBL] [Abstract][Full Text] [Related]
4. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis. Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274 [TBL] [Abstract][Full Text] [Related]
5. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis. Feng Y; Jiang Y; Wen T; Meng F; Shu X Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911 [TBL] [Abstract][Full Text] [Related]
6. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
7. CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma. Li M; Zhao J; Yang R; Cai R; Liu X; Xie J; Shu B; Qi S Cancer Sci; 2022 Apr; 113(4):1220-1234. PubMed ID: 35189004 [TBL] [Abstract][Full Text] [Related]
8. TOP2A and CENPF are synergistic master regulators activated in cervical cancer. Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625 [TBL] [Abstract][Full Text] [Related]
9. Identification of surrogate prognostic biomarkers for allergic asthma in nasal epithelial brushing samples by WGCNA. Liu Z; Li M; Fang X; Shen L; Yao W; Fang Z; Chen J; Feng X; Hu L; Zeng Z; Lin C; Weng J; Lai Y; Yi G J Cell Biochem; 2019 Apr; 120(4):5137-5150. PubMed ID: 30304558 [TBL] [Abstract][Full Text] [Related]
10. Identification of a 13‑mRNA signature for predicting disease progression and prognosis in patients with bladder cancer. Yin H; Zhang C; Gou X; He W; Gan D Oncol Rep; 2020 Feb; 43(2):379-394. PubMed ID: 31894276 [TBL] [Abstract][Full Text] [Related]
11. FOXM1 predicts disease progression in non-muscle invasive bladder cancer. Rinaldetti S; Wirtz R; Worst TS; Hartmann A; Breyer J; Dyrskjot L; Erben P J Cancer Res Clin Oncol; 2018 Sep; 144(9):1701-1709. PubMed ID: 29959570 [TBL] [Abstract][Full Text] [Related]
12. Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor. Wang L; Chen S; Luo Y; Yuan L; Peng T; Qian K; Liu X; Xiao Y; Wang X J Cell Physiol; 2019 Aug; 234(8):13439-13451. PubMed ID: 30618079 [TBL] [Abstract][Full Text] [Related]
13. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707 [TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Gene Databases in Discovering New Biomarkers and New Therapeutic Targets in Lung Cancer. Liu M; Yu X; Qu C; Xu S Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984548 [No Abstract] [Full Text] [Related]
15. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma. Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503 [TBL] [Abstract][Full Text] [Related]
16. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W Hereditas; 2019; 156():24. PubMed ID: 31333338 [TBL] [Abstract][Full Text] [Related]
17. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network. Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379 [TBL] [Abstract][Full Text] [Related]
18. Analysis of gene co‑expression network reveals prognostic significance of CNFN in patients with head and neck cancer. Liu B; Huang G; Zhu H; Ma Z; Tian X; Yin L; Gao X; He X Oncol Rep; 2019 Apr; 41(4):2168-2180. PubMed ID: 30816522 [TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis. Kong J; Shen S; Zhang Z; Wang W Cancer Biomark; 2020; 27(4):505-517. PubMed ID: 32116234 [TBL] [Abstract][Full Text] [Related]
20. LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions. Ding Y; Cao Q; Wang C; Duan H; Shen H Technol Cancer Res Treat; 2019 Jan; 18():1533033819876601. PubMed ID: 31558111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]